IRIS
CALABRO', Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 25.783
NA - Nord America 14.295
AS - Asia 12.126
SA - Sud America 1.948
Continente sconosciuto - Info sul continente non disponibili 1.014
AF - Africa 185
OC - Oceania 12
Totale 55.363
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 17.775
US - Stati Uniti d'America 14.005
SG - Singapore 4.578
CN - Cina 2.501
IE - Irlanda 2.473
HK - Hong Kong 1.784
BR - Brasile 1.640
VN - Vietnam 1.592
IT - Italia 1.149
GB - Regno Unito 979
UA - Ucraina 886
DE - Germania 814
KR - Corea 447
FR - Francia 437
IN - India 366
FI - Finlandia 331
SE - Svezia 311
GR - Grecia 223
TR - Turchia 218
BD - Bangladesh 156
AR - Argentina 131
CA - Canada 125
JP - Giappone 118
AT - Austria 101
MX - Messico 91
ID - Indonesia 68
NL - Olanda 54
PL - Polonia 51
BE - Belgio 49
ZA - Sudafrica 48
IQ - Iraq 47
EC - Ecuador 46
PK - Pakistan 45
MA - Marocco 38
ES - Italia 37
CO - Colombia 36
EG - Egitto 31
VE - Venezuela 25
KE - Kenya 22
UZ - Uzbekistan 22
CL - Cile 21
LT - Lituania 20
SA - Arabia Saudita 19
CR - Costa Rica 17
UY - Uruguay 17
JM - Giamaica 16
JO - Giordania 16
TH - Thailandia 16
AE - Emirati Arabi Uniti 15
NP - Nepal 15
PE - Perù 15
PY - Paraguay 15
TN - Tunisia 15
CH - Svizzera 14
IL - Israele 14
EU - Europa 12
IR - Iran 11
PH - Filippine 11
CZ - Repubblica Ceca 10
RS - Serbia 9
AL - Albania 8
MY - Malesia 8
AU - Australia 7
AZ - Azerbaigian 7
KZ - Kazakistan 7
OM - Oman 7
RO - Romania 7
TW - Taiwan 7
DK - Danimarca 6
DO - Repubblica Dominicana 6
HN - Honduras 6
PT - Portogallo 6
DZ - Algeria 5
GT - Guatemala 5
NO - Norvegia 5
PA - Panama 5
SV - El Salvador 5
AM - Armenia 4
BG - Bulgaria 4
EE - Estonia 4
ET - Etiopia 4
NG - Nigeria 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
PR - Porto Rico 4
BY - Bielorussia 3
CI - Costa d'Avorio 3
GA - Gabon 3
KG - Kirghizistan 3
MD - Moldavia 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
BN - Brunei Darussalam 2
BO - Bolivia 2
BW - Botswana 2
GE - Georgia 2
HU - Ungheria 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
Totale 54.325
Salva come PNG Salva come JPEG
Città #
Moscow 6.476
Dublin 2.454
Santa Clara 2.007
Singapore 1.857
San Jose 1.839
Hong Kong 1.757
Jacksonville 1.383
Chandler 1.101
Ashburn 851
Ho Chi Minh City 529
Hefei 505
Seoul 430
Hanoi 374
Princeton 362
Beijing 315
New York 277
Roxbury 276
Medford 241
Bengaluru 225
The Dalles 213
Boardman 200
Dallas 193
Naples 183
Los Angeles 173
Wilmington 145
Bremen 138
Houston 135
Cambridge 132
São Paulo 125
Ann Arbor 124
Da Nang 123
Nuremberg 111
Woodbridge 107
San Mateo 105
Helsinki 90
Des Moines 86
Council Bluffs 80
Milan 68
Orem 65
Atlanta 64
Nanjing 61
San Francisco 59
Haiphong 58
Munich 58
Rio de Janeiro 57
Falkenstein 53
Mountain View 49
Düsseldorf 48
Rome 48
Brussels 45
Brooklyn 43
Memphis 41
Belo Horizonte 38
Tokyo 38
Frankfurt am Main 37
Norwalk 37
Vienna 37
Phoenix 36
Curitiba 35
Guangzhou 35
Mexico City 34
Aversa 33
Caserta 32
Biên Hòa 31
Denver 31
Boston 30
Brasília 30
London 30
Shanghai 30
Chicago 29
Chennai 28
Montreal 28
Jinan 27
Amsterdam 26
Hải Dương 26
Johannesburg 25
Turku 25
Philadelphia 24
Porto Alegre 24
Toronto 24
Hyderabad 23
Thái Nguyên 23
Warsaw 23
Campinas 22
Ercolano 22
Lappeenranta 22
Columbus 21
Hangzhou 21
Ninh Bình 21
Thái Bình 21
Tianjin 21
Nanchang 20
Salvador 20
Istanbul 19
Nairobi 19
Seattle 19
Tashkent 19
Baghdad 18
Bắc Ninh 18
Bến Tre 18
Totale 27.809
Salva come PNG Salva come JPEG
Nome #
Clopidogrel versus aspirin for secondary prevention of coronary artery disease: a systematic review and individual patient data meta-analysis 569
Reduction of new onset of atrial fibrillation in patients treated with semaglutide: an updated systematic review and meta regression analysis of randomized controlled trials 321
Clopidogrel versus ticagrelor in high-bleeding risk patients presenting with acute coronary syndromes: insights from the multicenter START-ANTIPLATELET registry 276
Bioresorbable vascular scaffold implantation for the treatment of coronary in-stent restenosis: Results from a multicenter Italian experience. 267
Bisoprolol for treatment of symptomatic patients with obstructive hypertrophic cardiomyopathy. The BASIC (bisoprolol AS therapy in hypertrophic cardiomyopathy) study 265
Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: A Contemporary Perspective 262
Childhood obesity: An overview of laboratory medicine, exercise and microbiome 261
Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: A contemporary reappraisal 258
C-reactive protein is released in the coronary circulation and causes endothelial dysfunction in patients with acute coronary syndromes. 242
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study 223
The Biological Role of Vitamins in Athletes’ Muscle, Heart and Microbiota 195
The Risk of Sudden Unexpected Cardiac Death in Children: Epidemiology, Clinical Causes, and Prevention 189
Microbiota thrombus colonization may influence athero-thrombosis in hyperglycemic patients with ST segment elevation myocardialinfarction (STEMI). Marianella study 188
Adherence to proprotein convertase subtilisin/kexin 9 inhibitors in high cardiovascular risk patients: an Italian single-center experience 185
A simple method for the isolation, cultivation, and characterization of endothelial cells from rabbit coronary circulation 183
Activating stimuli induce platelet microRNA modulation and proteome reorganisation 182
C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation 180
Right ventricular hypertrabeculation associated with double-outlet left ventricle: exaggeration of a normal pattern or right ventricular cardiomyopathy? 178
Advanced Heart Failure in Special Population—Pediatric Age 176
Activated coagulation factor VII promotes smooth muscle cell proliferation in vitro. 169
Combined Effect of Mediterranean Diet and Aerobic Exercise on Weight Loss and Clinical Status in Obese Symptomatic Patients with Hypertrophic Cardiomyopathy 169
Adipose tissue and vascular inflammation in coronary artery disease. 168
. Accuratezza predittiva dell'elettrocardiogramma nell'identificazione dell'ipertrofia ventricolare sinistra. 167
Antithrombotic Therapy in Patients Undergoing Transcatheter Interventions for Structural Heart Disease 166
Cardiorenal Impact of SGLT-2 Inhibitors: A Conceptual Revolution in The Management of Type 2 Diabetes, Heart Failure and Chronic Kidney Disease 165
Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions: insights from the EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in iTalian cardiac care units Registry 164
Beyond cholesterol metabolism: The pleiotropic effects of proprotein convertase subtilisin/kexin type 9 (PCSK9). Genetics, mutations, expression, and perspective for long-term inhibition 163
Different effects of cardiac resynchronization therapy on left atrial function in patients with either idiopathic or ischaemic dilated cardiomyopathy: a two-dimensional speckle strain study. 161
A child cohort study from southern Italy enlarges the genetic spectrum of hypertrophic cardiomyopathy 161
Lomitapide in homozygous familial hypercholesterolemia: cardiology perspective from a single-center experience 160
A new integrated strategy for direct current cardioversion in non-valvular atrial fibrillation patients using short term rivaroxaban administration: The MonaldiVert real life experience 159
Effect of dynamic myocardial dyssynchrony on mitral regurgitation during supine bicycle exercise stress echocardiography in patients with idiopathic dilated cardiomyopathy and 'narrow' QRS 159
Antithrombotic therapy in patients with atrial high-rate episodes (AHREs): Current evidence and open questions 158
A new character on the scene of cardiorenal syndrome 157
Natural history of left ventricular hypertrophy in infants of diabetic mothers 157
Adherence to PCSK9 inhibitors in high cardiovascular risk patients in real-world setting: results from a single-center experience and comparison with statin therapy 156
Diagnosis and Management of Cardiovascular Involvement in Fabry Disease 156
Association between left atrial myocardial function and exercise capacity in patients with either idiophatic or ischemic dilated cardiomyopathy: a two-dimensional speckle strain study 155
Aortopathies in mouse models of Pompe, Fabry and Mucopolysaccharidosis IIIB lysosomal storage diseases 155
Medical treatment of patients with hypertrophic cardiomyopathy: An overview of current and emerging therapy 154
Access-Site Crossover in Patients With Acute Coronary Syndrome Undergoing Invasive Management 153
Efficacy and safety of dabigatran in a "real-life" population at high thromboembolic and hemorrhagic risk: data from MonaldiCare registry 152
A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery Surgery After Stenting 2 152
New Frontiers in the Treatment of Homozygous Familial Hypercholesterolemia 152
Adipose tissue-mediated inflammation: the missing link between obesity and cardiovascular disease? 151
Effects of incretin treatment on cardiovascular outcomes in diabetic STEMI-patients with culprit obstructive and multivessel non obstructive-coronary-stenosis 151
. Left atrial strain/strain rate analylisis in patients with dilated cardiomyopathy. Correlation with clinical, electrocardiographic and echocardiographic findings 149
Bioresorbable vascular scaffold versus everolimus-eluting stents or drug eluting balloon for the treatment of coronary in-stent restenosis: 1-Year follow-up of a propensity score matching comparison (the BIORESOLVE-ISR Study) 149
. Plasma CT1 analysis in patients with hypertrophic cardiomyopathy. 148
[The COMPASS study] 148
Multiple hormonal and metabolic deficiency syndrome predicts outcome in heart failure: The T.O.S.CA. Registry 148
[Device therapy in chronic heart failure: a case of hypertrophic cardiomyopathy treated with cardiac contractility modulation therapy] 146
. L’analisi DMI del ventricolo destro a riposo predice la performance all’apice dello sforzo dei pazienti adulti operati per tetralogia di Fallot 145
.: Correlations between right ventricular myocardial function and cardiac performance during exercise in adult patients late after repair of tetralogy of Fallot 145
Antiplatelet therapy for non-ST-Segment elevation myocardial infarction in complex "real" Clinical Scenarios: A Consensus Document of the "campania NSTEMI Study Group" 145
Cardiotrophin-1 and TNF-alpha circulating levels at rest and during cardiopulmonary exercise test in athletes and healthy individuals 144
Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: the emerging role of the Cardiomyopathy Team 143
Activated platelets stimulate tissue factor expression in smooth muscle cells 142
. Ultrasonic myocardial tissue characterization in normal and abnormal right ventricle 142
Antithrombotic Therapy Optimization in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention 140
Right ventricular myocardial function in patients with either idiopathic or ischemic dilated cardiomyopathy without clinical sign of right heart failure: effects of cardiac resynchronization therapy. 140
Acute kidney injury in patients with acute coronary syndrome undergoing invasive management treated with bivalirudin vs. unfractionated heparin: insights from the MATRIX trial 140
De-escalation strategies in patients with acute coronary syndrome: a step towards precision medicine 140
Nuove prospettive nella terapia dello scompenso cardiaco: Farmacogenetica, Farmacogenomica e terapia cellulare. 139
Which hemodynamic parameter predicts nitroglycerin-potentiated head-up tilt test response? 138
. Integrated backscatter analysis of functional and textural findings in young patients with different pathophysiological models of right ventricular overload 136
Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry 136
SGLT-2 inhibitors and in-stent restenosis-related events after acute myocardial infarction: an observational study in patients with type 2 diabetes 135
Cardiovascular Involvement in Transthyretin Cardiac Amyloidosis 134
ICARUS score for predicting peri-procedural bleeding in patients undergoing percutaneous coronary intervention with cangrelor 134
Impact of GEne Polymorphisms, Platelet REactivity and the SYNTAX Score on 1-Year Clinical Outcomes in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: The GEPRESS Study. 134
Expression of exogenous tissue factor pathway inhibitor in vivo suppresses thrombus formation in injured rabbit carotid arteries 134
Feasibility and usefulness of right ventricular ultrasonic tissue characterization with integrated backscatter in patients with unsuccessfully operatively "repaired" tetralogy of Fallot 134
Clinical findings after bioresorbable vascular scaffold implantation in an unrestricted cohort of patients with ST-segment elevation myocardial infarction (from the RAI registry) 134
Aortic Root Diameter in Highly-Trained Competitive Athletes: Reference Values According to Sport and Prevalence of Aortic Enlargement 133
Inflammation and cardiovascular disease: from pathogenesis to therapeutic target 133
Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A 'state-of-the-art' paper. 133
Release of C-reactive protein in response to inflammatory cytokines by human adipocytes: linking obesity to vascular inflammation 133
Non-ST-elevation myocardial infarction outcomes in patients with type 2 diabetes with non-obstructive coronary artery stenosis: Effects of incretin treatment 133
Registrazione del potenziale di azione monofasico e del recupero ventricolare a seguito di variazioni acute del sovraccarico di volume: evidenza in vivo del feedback elettromeccanico 132
Effect of Body Mass Index on Ischemic and Bleeding Events in Patients Presenting With Acute Coronary Syndromes (from the START-ANTIPLATELET Registry) 132
Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: Insights from the START-ANTIPLATELET registry 132
New frontiers in antiplatelet therapy: guided therapy and de-escalation after acute coronary syndrome or percutaneous coronary intervention 131
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 131
Obesità in età pediatrica ed ipertensione arteriosa 131
Prevalence and clinical significance of right ventricular pulmonary arterial uncoupling in cardiac amyloidosis 131
Atrial Fibrillation, Heart Failure Phenotypes, and Mortality Risk in the Nationwide START Registry: A Propensity Score Matching Analysis 130
Anti-inflammatory therapies for cardiovascular diseases: novel evidence, clinical implications, and future perspectives 130
The Role of Genetic Testing in Patients with Heritable Thoracic Aortic Diseases 130
Noninvasive risk stratification prevents sudden death due to paroxysmal atrial fibrillation in hypertrophic cardiomyopathy 129
Low-Dose Ticagrelor in Patients With High Ischemic Risk and Previous Myocardial Infarction: A Multicenter Prospective Real-World Observational Study 129
[Evaluation and percutaneous treatment of severely calcified coronary lesions] 129
Induction of tissue factor in the arterial wall during recurrent thrombus formation 128
Coronary Physiology Assessment for the Diagnosis and Treatment of Coronary Artery Disease 128
Multidisciplinary In-Depth Investigation in a Young Athlete Suffering from Syncope Caused by Myocardial Bridge 128
Pathophysiology, Functional Assessment and Prognostic Implications of Nutritional Disorders in Systemic Amyloidosis 127
[Debate on antiplatelet monotherapy: P2Y12 inhibitor monotherapy in patients with coronary artery disease] 127
A Prospective Study to Evaluate the Effectiveness of Edoxaban for the Resolution of Left Atrial Thrombosis in Patients with Atrial Fibrillation 127
Long-Term Antithrombotic Therapy in Patients with Atrial Fibrillation and Percutaneous Coronary Intervention 126
Role of LipoprotEin(a) in CardiovascuLar diseases and premature acute coronary syndromes (RELACS study): Impact of Lipoprotein(a) levels on the premature coronary event and the severity of coronary artery disease 126
Totale 16.211
Salva come PNG Salva come JPEG
Categoria #
all - tutte 196.302
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 196.302
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.261 0 13 26 82 785 27 36 148 86 184 147 727
2022/20234.257 452 145 58 348 401 307 10 206 2.136 32 78 84
2023/20242.109 144 59 76 161 680 223 86 74 12 57 155 382
2024/20257.551 26 74 35 213 1.164 1.071 1.092 614 956 1.186 644 476
2025/202631.312 1.110 1.504 1.635 1.545 2.349 16.660 1.920 1.546 1.220 971 553 299
2026/20272.294 800 1.494 0 0 0 0 0 0 0 0 0 0
Totale 55.363